Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis - Related Studies

Oral Budesonide in the Treatment of Patients With Primary Biliary Cirrhosis and Overlap Features of Autoimmune Hepatitis (PBC)

This study has been terminated.

( Lack of enrollment )

Study NCT00587119 Information provided by Mayo Clinic

First Received: December 21, 2007 Last Updated: July 10, 2009 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Additional conditions recognized in this trial

More general conditions related to this trial

Interventions listed in this trial

Budesonide

More general drug interventions related to this trial

Sponsors listed in this trial

Mayo Clinic